PanGen Biotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	66,864	73,520	73,462	69,405	99,783	97,864
Market Cap Growth	5.37%	0.08%	5.85%	-30.44%	1.96%	30.63%
Enterprise Value	54,554	69,814	74,767	67,446	92,638	96,121
Last Close Price	4955.00	5700.00	6880.00	6500.00	9350.00	10150.00
PE Ratio	39.09	77.91	-	-	-	-
Forward PE	-	91.30	91.30	91.30	91.30	91.30
PS Ratio	4.38	5.01	10.04	10.68	12.57	15.81
PB Ratio	2.23	2.95	5.85	4.03	4.73	6.89
P/TBV Ratio	2.30	3.05	6.29	4.10	4.80	7.02
P/FCF Ratio	-	27.99	-	-	-	-
P/OCF Ratio	218.58	24.61	-	-	-	-
EV/Sales Ratio	3.57	4.76	10.22	10.38	11.67	15.53
EV/EBITDA Ratio	17.64	28.06	-	-	-	-
EV/EBIT Ratio	33.41	68.43	-	-	-	-
EV/FCF Ratio	-124.61	26.58	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.16	0	0.89	1.30
Debt / EBITDA Ratio	0.30	0.33	-	-	-	-
Debt / FCF Ratio	-	0.31	-	-	-	-
Net Debt / Equity Ratio	-0.41	-0.43	0.14	-0.05	-0.26	-0.02
Net Debt / EBITDA Ratio	-3.98	-4.26	-0.69	0.28	3.08	0.14
Net Debt / FCF Ratio	28.12	-4.04	-0.47	0.20	1.14	0.05
Asset Turnover	0.53	0.57	0.35	0.20	0.20	0.16
Inventory Turnover	1.46	1.48	0.94	1.07	1.82	2.12
Quick Ratio	5.68	4.98	0.42	1.55	1.28	0.97
Current Ratio	8.52	7.16	1.72	7.59	1.57	1.20
Return on Equity (ROE)	6.83%	5.04%	-30.14%	-23.46%	-18.75%	-26.69%
Return on Assets (ROA)	3.51%	2.49%	-12.75%	-8.97%	-5.17%	-6.13%
Return on Invested Capital (ROIC)	10.05%	6.69%	-27.46%	-28.62%	-22.21%	-29.17%
Return on Capital Employed (ROCE)	5.40%	3.70%	-28.10%	-23.50%	-14.10%	-22.80%
Earnings Yield	2.45%	1.28%	-6.11%	-6.48%	-3.32%	-4.45%
FCF Yield	-0.65%	3.57%	-5.27%	-6.10%	-4.76%	-5.56%
Buyback Yield / Dilution	-16.88%	-7.03%	-0.13%	-4.47%	-6.02%	0.04%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.